Literature DB >> 472728

Long-term choline treatment of memory-impaired elderly patients.

S H Ferris, G Sathananthan, B Reisberg, S Gershon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 472728     DOI： 10.1126/science.472728

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.

Authors:  G L Corona; M L Cucchi; P Frattini; G Santagostino; S Schinelli; A Romani; A Pola; F Zerbi; F Savoldi
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

2.  Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice.

Authors:  J F Flood; G E Smith; A Cherkin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

4.  Effect of combined or separate administration of piracetam and choline on learning and memory in the rat.

Authors:  A Ennaceur; J Delacour
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Authors:  M W Vernon; E M Sorkin
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

6.  Attenuation of scopolamine-induced amnesia in mice.

Authors:  W S Stone; C E Croul; P E Gold
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 7.  Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps.

Authors:  Raymond T Bartus; Reginald L Dean
Journal:  Psychopharmacology (Berl)       Date:  2008-11-15       Impact factor: 4.530

8.  Scopolamine challenges in Alzheimer's disease.

Authors:  T Sunderland; P Tariot; D L Murphy; H Weingartner; E A Mueller; R M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.